Newzenpharma has developed compositions and methods for treating prostate cancer by targeting DNA repair within cancer/tumor cells. The technology inhibits BER capacity in cancer cells without compromising normal cell growth, slowing down tumor growth and metastasis. Compared to currently available chemotherapy treatment options for castrate-resistant prostate cancer, these methods provide effective treatment with fewer side effects but Newzen-138 has no side effects.
Company Details
- Founded
- 2017
- Address
- Us Hyw 1 #1145, Princeton,nj 08540,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://newzenpharma.com
- Keywords
- Oncology, Biologics, Cell & Gene Therapy.
- HQ
- Princeton, NJ
Newzenpharma Questions
Newzenpharma's website is http://newzenpharma.com
Newzenpharma's LinkedIn profile is https://www.linkedin.com/company/newzenpharma
Newzenpharma's industry is
Pharmaceutical Manufacturing
Newzenpharma's top competitors are
Abelzeta,
Ocugen,
The Honors College Of Rutgers - New Brunswick,
Sable Therapeutics,
3daughters,
Stablebio,
Correct Rx Pharmacy Services, Inc.,
Visual Science,
Shanton Pharma,
Rx Communications.
Newzenpharma's categories are Pharmaceutical Manufacturing
Newzenpharma's founding year is 2017
